Skip to main content

Table 4 Subset analyses of hypomagnesemia

From: Correlation between blood magnesium and calcium concentration in patients treated with an anti-EGFR antibody

 

Hypomagnesemia

Grade 0

Grade 1<

p

No

 

9

13

 

Sexa)

Men/Women

6/3

11/2

0.316

Body Hight (cm)b)

Mean ± S.D.

160.5 ± 9.6

164.4 ± 7.3

0.556

Body Weight (kg)b)

Mean ± S.D.

57.3 ± 7.7

58.6 ± 10.2

0.647

PSa)

0/1or 2

6/3

7/6

0.439

AST (IU/l)b)

Mean ± S.D.

20.1 ± 3.3

20.6 ± 5.1

0.794

ALT (IU/l)b)

Mean ± S.D.

14.4 ± 7.3

16.0 ± 7.1

0.695

sCre (mg/dl)b)

Mean ± S.D.

0.65 ± 0.10

0.79 ± 0.39

0.794

Neu (/mm3)b)

Mean ± S.D.

3253 ± 907

4037 ± 1704

0.431

WBC (/mm3)b)

Mean ± S.D.

5211 ± 1230

6438 ± 1815

0.144

PLT (/mm3)b)

Mean ± S.D.

193,778 ± 43,260

216,308 ± 64,165

0.556

Hb (g/dl)b)

Mean ± S.D.

11.83 ± 1.67

11.56 ± 1.83

0.948

Mg (mg/dl)b)

Mean ± S.D.

2.14 ± 0.25

2.12 ± 0.21

0.749

Ca (mg/dl)b)

Mean ± S.D.

10.00 ± 0.37

9.93 ± 0.32

0.845

Combination regimen

FOLFIRI base

6

9

 

FOLFOX base

0

2

CPT-11 alone

2

0

Monotherapy

1

2

  1. a)χ2test, b)Mann-Whitney’s U test